Thermo Fisher Scientific reported a 5% increase in revenue to $11.40 billion for the fourth quarter of 2024. GAAP diluted EPS grew by 14% to $4.78, and adjusted EPS grew by 8% to $6.10. The company highlighted its focus on strengthening industry leadership and executing its capital deployment strategy.
Fourth quarter revenue grew 5% to $11.40 billion.
Fourth quarter GAAP diluted earnings per share (EPS) grew 14% to $4.78.
Fourth quarter adjusted EPS grew 8% to $6.10.
The company launched innovative new products and strengthened its commercial engine.
The company will provide 2025 financial guidance during its earnings conference call this morning at 8:30 a.m. Eastern Time.
Visualization of income flow from segment revenue to net income